Targeting thioredoxin reductase 1 reduction in cancer cells inhibits self-sufficient growth and DNA replication.
Thioredoxin reductase 1 (TR1) is a major redox regulator in mammalian cells. As an important antioxidant selenoprotein, TR1 is thought to participate in cancer prevention, but is also known to be over-expressed in many cancer cells. Numerous cancer drugs inhibit TR1, and this protein has been propos...
Main Authors: | Min-Hyuk Yoo, Xue-Ming Xu, Bradley A Carlson, Andrew D Patterson, Vadim N Gladyshev, Dolph L Hatfield |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2007-10-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2040202?pdf=render |
Similar Items
-
HIF-independent regulation of thioredoxin reductase 1 contributes to the high levels of reactive oxygen species induced by hypoxia.
by: Salvador Naranjo-Suarez, et al.
Published: (2012-01-01) -
Abrogated thioredoxin system causes increased sensitivity to TNF-α-induced apoptosis via enrichment of p-ERK 1/2 in the nucleus.
by: Min-Hyuk Yoo, et al.
Published: (2013-01-01) -
The 15kDa selenoprotein and thioredoxin reductase 1 promote colon cancer by different pathways.
by: Petra A Tsuji, et al.
Published: (2015-01-01) -
Structural analysis of glutaredoxin domain of Mus musculus thioredoxin glutathione reductase.
by: Olena Dobrovolska, et al.
Published: (2012-01-01) -
Mouse Models Targeting Selenocysteine tRNA Expression for Elucidating the Role of Selenoproteins in Health and Development
by: Dolph L. Hatfield, et al.
Published: (2009-09-01)